已为您找到该学者15条结果 成果回收站
【期刊论文】Activation of Intestinal Mucosal Immunity in Tumor-bearing Mice by Lactoferrin
王文萍, Wen-Ping Wang, , Masaaki Iigo, Jun Sato, Kazunori Sekine, Isamu Adachi, and Hiroyuki Tsuda
Jpn. J. Cancer Res. 91, 1022-1027, October 2000,-0001,():
-1年11月30日
We have previously demonstrated that oral administration of bovine lactoferrin (bLF) markedly increases CD4+ and CD8+ T cells and NK (asialoGM1+) cells in the blood of tumor-bearing mice and enhances anti-metastatic activity. In this paper, we document that oral administration of bLF and bLF-hydrolysate (bLFH) is associated with strong increases in CD4+ and CD8+ T, as well as asialoGM1+ cells in lymphoid tissues and lamina propria of the small intestine in mice, especially in tumor-bearing animals in which Co26Lu cells were implanted subcutaneously. Moreover, IgM+ and IgA+ B cells in lamina propria of the small intestine were also significantly increased by bLF and bLFH. Bovine apo-transferrin (bTF) did not exhibit such activity. In the colon, only CD8+ cells were significantly increased by treatment with bLF, while asialoGM1+ cells were significantly decreased. bLF and bLFH induced cytokines to activate T, B and asialoGM1+ cells. Administration of bLF and bLFH, but not bTF, increased production of interleukin-18 (IL-18), interferon-gamma (IFN-γ ) and caspase-1 in the mucosa of the small intestine. Particularly high levels of IL-18 were found in the epithelial cells of the small intestine. Moreover, administration of bLF and bLFH, but not bTF, induced IFN-γ presenting cells in the small intestine. Caspase-1, which processes proIL-18 to mature IL-18, was also induced in the epithelial cells of the small intestine following treatment with bLF and bLFH, but not with bTF. These results suggest that enhanced production of IL-18 and IFN-γ and caspase-1 induction by treatment with bLF may be important for elevation of intestinal mucosal immunity.
Lactoferrin, Small intestine, Interleukin-18, Interferon-gamma, Caspase-1
-
61浏览
-
0点赞
-
0收藏
-
0分享
-
76下载
-
0
-
引用
【期刊论文】癌性疼痛患者从吗啡向芬太尼持续注入转换的换算比例的研究
王文萍, 安达勇
肿瘤2006年11月第26卷第11期/Tumor Vol. 26, No. 11, Nov., 2006,-0001,():
-1年11月30日
目的:探讨从吗啡向芬太尼持续注入转换的适当换算比例。方法:通过20例癌性疼痛患者的回顾性临床调查,对疼痛程度、药物不良反应及治疗满意度进行评价。结果:本组转换后1周内稳定(转换前后疼痛强度无明显变化)(Good组)的有17例,不稳定(Poor组)的有3例。芬太尼注射剂和吗啡有同等的镇痛效果;转换后能够减轻副作用、提高满意度。结论:推荐从低剂量吗啡向芬太尼注射剂转换的换算比例是72:1,并且推测从非低用量吗啡向芬太尼注射剂转换的换算比例小于72:1有可能达到稳定。但不可能确定从吗啡向芬太尼持续注入转换的具体换算比例,应考虑转换前吗啡用量,再行确定转换的具体比例。
肿瘤, 疼痛, 吗啡, 芬太尼/投药和剂量
-
83浏览
-
0点赞
-
0收藏
-
0分享
-
184下载
-
0
-
引用
王文萍 , 姜良铎, 饭乡正明, 佐藤淳, 津田洋幸
中国中医基础医学杂志2001年第7卷第12期/Chinese J Basic Med TCM 2001, Vol. 7, No. 12 (总第903页),-0001,():
-1年11月30日
肠积消, IFN, 肺转移
-
48浏览
-
0点赞
-
0收藏
-
0分享
-
103下载
-
0
-
引用
王文萍 , 饭乡正明, 津西洋幸
肿瘤学杂志2002年第8卷第1期,-0001,():
-1年11月30日
Lactferrin (LF)是一种铁结台性糖蛋口质,最初作为抗菌蛋白质被广泛研究。 LF在多种哺乳类乳汁中广泛含有,但在人乳中含量最高。 LF能够争夺微生物生长所需铁离子,并且能激活自然杀伤(NK)细胞和中性粒细胞,诱导集落刺激活性,刺激淋巴因子激活杀伤(LAK)细胞,增强巨噬细胞的细胞毒作用,调整肠内环境改善肠蠕动,预防 c型肝炎病毒的感染,预防癌发生及癌转移,本文对此作了综述。
大肠肿瘤, 转移, 预防, Lactferrin
-
76浏览
-
0点赞
-
0收藏
-
0分享
-
85下载
-
0
-
引用
-
41浏览
-
0点赞
-
0收藏
-
0分享
-
180下载
-
0
-
引用